Researchers from the Liverpool School of Tropical Medicine (LSTM) working in partnership with colleagues from the Kenya Medical Research Institute (KEMRI) have shown the large potential impact of a completely...

New findings from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), confirm dihydroartemisinin-piperaquine, the first-line treatment for...